Bethea ED, Chen Q, Hur C, et al. Cost-effectiveness of Treating Acute versus Chronic Hepatitis C Infection Using Direct-Acting Antivirals. AASLD 2017, abstract 24.
NAFLD verhoogt risico op fatale en niet-fatale CV-gebeurtenissen
sep 2021 | Hepatologie